<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02485002</url>
  </required_header>
  <id_info>
    <org_study_id>SU-RIRS-UAS-02</org_study_id>
    <nct_id>NCT02485002</nct_id>
  </id_info>
  <brief_title>Differences in Urine NGAL Levels in Patients Undergoing RIRS With or Without Ureteral Access Sheath</brief_title>
  <official_title>Differences in Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels in Patients Undergoing Retrograde Intrarenal Surgery (RIRS) With or Without Ureteral Access Sheath (UAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Selcuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Selcuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will include patients aged between 18 and 65 who will undergo retrograde
      infrarenal surgery (RIRS) due to renal stone(s). A total of 60 patients (male or female) will
      be recruited, and will be randomized into 2 groups consisting of 30 patients in each group.
      The first group of patients will undergo RIRS with a ureteral access sheath (UAS) positioned
      prior to surgery; and the second group will undergo RIRS without UAS. As use of UAS decreases
      the pressure in the renal pelvis during RIRS, it is aimed to evaluate whether using UAS or
      not affects the kidney functions. besides the routine kidney function tests, namely urea and
      creatinine, neutrophil gelatinase-associated lipocalin (NGAL) (a more specific and early
      marker of kidney function) will be used to assess the differences in the kidney functions.
      Preoperative blood urea and creatinine levels and urine NGAL levels will be studied for all
      patients. After the surgery, blood urea and creatinine levels will be again studied as well
      as urine NGAL levels at postoperative 2nd hour, 72nd hour and 1st week.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urine NGAL level (ng/mL)</measure>
    <time_frame>Within the first 7 days after surgery (RIRS)</time_frame>
    <description>Determination of any impairment in renal function when ureteral access sheath is not used during RIRS by measuring urine NGAL level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood urea level (mg/dL) and creatinine level (mg/dL)</measure>
    <time_frame>Within the first 7 days after surgery (RIRS)</time_frame>
    <description>Determination of any impairment in renal function when ureteral access sheath is not used during RIRS by measuring blood urea and creatinine levels.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Urolithiasis</condition>
  <arm_group>
    <arm_group_label>UAS (+)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RIRS with ureteral access sheath: A ureteral access sheath (UAS) will be positioned into the ureter of the patient prior to the insertion of the flexible ureterorenoscope (RIRS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UAS (-)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RIRS without ureteral access sheath: A ureteral access sheath (UAS) will not be positioned into the ureter of the patient prior to the insertion of the flexible ureterorenoscope (RIRS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RIRS with ureteral access sheath</intervention_name>
    <description>Ureteral access sheath will be used during RIRS.</description>
    <arm_group_label>UAS (+)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RIRS without ureteral access sheath</intervention_name>
    <description>Ureteral access sheath will not be used during RIRS.</description>
    <arm_group_label>UAS (-)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being between 18-65 years old

          -  Having an indication of retrograde infrarenal surgery (RIRS) due to kidney stone

        Exclusion Criteria:

          -  Patients with uncontrolled diabetes mellitus and diabetic nephropathy

          -  Patients with blood pressure &gt; 140/80 mmHg despite regular use of antihypertensive
             agent(s)

          -  Patients with chronic kidney failure who need dialysis

          -  Patients who have had prerenal, renal or postrenal acute kidney failure 3 months or
             much earlier

          -  Patients who have had pyelonephritis 3 months or much earlier

          -  Patients younger than 18 years or older than 65 years

          -  Patients who have undergone a kidney surgery within the last 3 months and have
             abnormal kidney function tests

          -  Patients with a concomitant ureter stone who will undergo an endoscopic ureter stone
             treatment at the same session
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ozcan Kilic, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Selcuk University, School of Medicine, Department of Urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Selcuk University, School of Medicine, Department of Urology</name>
      <address>
        <city>Konya</city>
        <zip>42075</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004 Feb;18(1):33-6.</citation>
    <PMID>15006050</PMID>
  </reference>
  <reference>
    <citation>Kourambas J, Byrne RR, Preminger GM. Does a ureteral access sheath facilitate ureteroscopy? J Urol. 2001 Mar;165(3):789-93.</citation>
    <PMID>11176469</PMID>
  </reference>
  <reference>
    <citation>L'esperance JO, Ekeruo WO, Scales CD Jr, Marguet CG, Springhart WP, Maloney ME, Albala DM, Preminger GM. Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Urology. 2005 Aug;66(2):252-5.</citation>
    <PMID>16040093</PMID>
  </reference>
  <reference>
    <citation>Stern JM, Yiee J, Park S. Safety and efficacy of ureteral access sheaths. J Endourol. 2007 Feb;21(2):119-23. Review.</citation>
    <PMID>17338606</PMID>
  </reference>
  <reference>
    <citation>Ichino M, Kusaka M, Kuroyanagi Y, Mori T, Morooka M, Sasaki H, Shiroki R, Shishido S, Kurahashi H, Hoshinaga K. Urinary neutrophil-gelatinase associated lipocalin is a potential noninvasive marker for renal scarring in patients with vesicoureteral reflux. J Urol. 2010 May;183(5):2001-7. doi: 10.1016/j.juro.2010.01.031. Epub 2010 Mar 19.</citation>
    <PMID>20303517</PMID>
  </reference>
  <reference>
    <citation>Abassi Z, Shalabi A, Sohotnik R, Nativ O, Awad H, Bishara B, Frajewicki V, Sukhotnik I, Abbasi A, Nativ O. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J Urol. 2013 Apr;189(4):1559-66. doi: 10.1016/j.juro.2012.10.029. Epub 2012 Oct 22.</citation>
    <PMID>23085062</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2015</study_first_submitted>
  <study_first_submitted_qc>June 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2015</study_first_posted>
  <last_update_submitted>May 16, 2016</last_update_submitted>
  <last_update_submitted_qc>May 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Selcuk University</investigator_affiliation>
    <investigator_full_name>Ozcan Kilic</investigator_full_name>
    <investigator_title>Associate Professor, M.D.</investigator_title>
  </responsible_party>
  <keyword>kidney</keyword>
  <keyword>kidney stone</keyword>
  <keyword>NGAL</keyword>
  <keyword>ureterorenoscopy</keyword>
  <keyword>intrarenal surgery</keyword>
  <keyword>kidney function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

